Filter
49
Filtered Results: 49
Text search:
Chagas
Coalition
Featured
Recommendations
2
New Publications
18
Language
Document type
No document type
19
Studies & Reports
11
Strategic & Response Plan
7
Resource Platforms
5
Manuals
2
Guidelines
2
App
1
Videos
1
Fact sheets
1
Countries / Regions
Global
9
Venezuela
3
Latin America and the Carribbean
3
Ghana
2
Nigeria
1
Malawi
1
Zimbabwe
1
Tanzania
1
Western and Central Europe
1
Paraguay
1
South Africa
1
Uganda
1
Brazil
1
Namibia
1
Ethiopia
1
Botswana
1
Zambia
1
Liberia
1
India
1
Authors & Publishers
Publication Years
Category
NTDs & Others
6
Policies
4
Studies & Reports
4
Chagas
3
Disease Prevention & Control
3
Trachoma
2
Lymphaticfilariasis
2
Statistics
2
WASH
2
Leprosy
2
Non-communicable Diseases
2
Hepatitis
1
Helminthiasis
1
Pharmacy & Technology
1
Disaster Preparedness
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
COVID-19
1
Monitoring & Evaluation
1
Yellow Fever
1
Capacity Building
1
Humanitarian Crisis
1
Reproductive Health
1
Toolboxes
Overview, Studies & Reports
6
Capacity Building & Resources
5
Information & Education Material (IEC)
3
Latin America & the Carribean
3
Reports & Studies
3
One Health
2
Chagas
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
ART Drug Resistance
1
Local Action
1
Treatment & Prevention
1
Clinical Aspects
1
Yellow Fever Prevention & Control
1
Children & Adolescents
1
WASH
1
Public Health
1
Health Equity & Equality
1
Prevention & Preparedness
1
Appeals and Response Plans
1
Country specific documents
1
Rational use of Medicine
1
Guiding documents and principles
1
General documents One Health
1
Zoonoses
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
Clinical Aspects & Diagnostics
1
NTDs General
1
Vector control
1
Overview & Statistics
1
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Washington, D.C., ÉUA, du 23 au 27 septembre 2018
Point 8.3 de l'ordre du jour provisoire
CD56/INF/3 14 juillet 2018
Original: anglais
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
WHO Technical Series 971
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
Communicable diseases are a major cause of suffering, disability and death in the world. The World Health
Organization’s Programme on Communicable Diseases provides technical guidance and support to national governments to organize and implement programmes aimed at setting up or strengthening ong...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs). This work is described in the NTD ...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnosis for co-infection can be detected simultaneously using th...
The report brings a new dimension to long-term thinking about the future approach to these diseases. For the fi rst time, it sets out financing needs, options, and targets for meeting WHO Roadmap goals by 2020, but also for reaching universal coverage of all people in need by 2030. Th e report makes...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
